HUTCHMED (00013): Executive Director and Chief Financial Officer Chi-chung Cheng appointed as acting Chief Executive Officer.
Huahuang Medicine (00013) issued an announcement that the Board of Directors was informed that the executive director of the company, Mr. Su Weiguo, will temporarily suspend his duties due to health reasons...
HUTCHMED (00013) announced that the Board of Directors has been informed that the Company's Executive Director, Mr. Su Weiguo, will temporarily suspend his duties as Chief Executive Officer for health reasons.
In light of this, the Board of Directors has appointed Mr. Zhou Zefeng, the Company's Executive Director and Chief Financial Officer, to serve as Acting Chief Executive Officer with immediate effect.
In addition to his role as Chief Financial Officer, Mr. Zhou will also be responsible for overseeing the Company's daily operations and management during the transition period to ensure the continuity of the Company's leadership and decision-making.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


